Evidence map›Paper›PMID 36453571›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.

Meng Wu, Jian-Bin Zhang, Yi-Wei Xiong, Yong-Xu Zhao, Meng-Ge Zheng, Xia-Li Huang, Fang Huang, Xing-Xing Wu, Xue Li, Wei-Jiao Fan and 15 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Research progress on lysine acetylation (Review).International journal of molecular medicine · 2026
    Review
  2. Advances in sirtuin research in lung diseases (Review).International journal of molecular medicine · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Senescent SPP1Molecular cancer · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Harnessing innate immune pathways for therapeutic advancement in cancer.Signal transduction and targeted therapy · 2024
    Review
  16. Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 2 countries.

Meng WuInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Jian-Bin ZhangInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Yi-Wei XiongInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Yong-Xu ZhaoInstitute of Health Sciences and Shanghai Key Laboratory for Tumour Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Meng-Ge ZhengInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Xia-Li HuangInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Fang HuangInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Xing-Xing WuInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Xue LiInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Wei-Jiao FanInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Lin HuInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Yuan-Yuan ZengInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Xia-Ju ChengInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Ji-Cheng YueInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Juan-Juan DuInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Nan-Nan ChenInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Wen-Xiang WeiInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Qing-Hua YaoDepartment of Integrated Chinese and Western Medicine, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 210022, China.
Xiao-Mei LuClinical Medical Research Institute, First Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830054, China.
Chao HuangInstitute of Health Sciences and Shanghai Key Laboratory for Tumour Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Jiong DengInstitute of Health Sciences and Shanghai Key Laboratory for Tumour Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhi-Jie ChangState Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, Beijing, 100084, China.
He-Bin LiuInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Ting C ZhaoDepartments of Surgery and Plastic Surgery, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, 02903, USA.
Y Eugene ChinnInstitute of Clinical Medicine Research, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.ORCID 0000-0003-4962-1396
Soochow University · CNShanghai Jiao Tong University · CNBrown University · USTsinghua University · CNXinjiang Medical University · CNZhejiang Cancer Hospital · CN

Funding

China Ministry of Science and Technology 2018YFC1705505China Ministry of Science and Technology 216YFC1302402China Natural Science Foundation 81820108023China Natural Science Foundation 82030077China Natural Science Foundation U1603284Ministry of Science and Technology of the People's Republic of China 2018YFC1705505Ministry of Science and Technology of the People's Republic of China 216YFC1302402Priority Academic Program Development of Jiangsu Higher Education InstitutionsSoochow University Research Development Fund 31801058Soochow University Research Development Fund 81902977Soochow University Research Development Fund Q424900220Zhejiang Provincail Natural Science Foundation of China Z23H160028
6 · The paper itself

Abstract

Acetylation of extracellular proteins has been observed in many independent studies where particular attention has been given to the dynamic change of the microenvironmental protein post-translational modifications. While extracellular proteins can be acetylated within the cells prior to their micro-environmental distribution, their deacetylation in a tumor microenvironment remains elusive. Here it is described that multiple acetyl-vWA domain-carrying proteins including integrin β3 (ITGB3) and collagen 6A (COL6A) are deacetylated by Sirtuin family member SIRT2 in extracellular space. SIRT2 is secreted by macrophages following toll-like receptor (TLR) family member TLR4 or TLR2 activation. TLR-activated SIRT2 undergoes autophagosome translocation. TNF receptor associated factor 6 (TRAF6)-mediated autophagy flux in response to TLR2/4 activation can then pump SIRT2 into the microenvironment to function as extracellular SIRT2 (eSIRT2). In the extracellular space, eSIRT2 deacetylates ITGB3 on aK416 involved in cell attachment and migration, leading to a promotion of cancer cell metastasis. In lung cancer patients, significantly increased serum eSIRT2 level correlates with dramatically decreased ITGB3-K416 acetylation in cancer cells. Thus, the extracellular space is a subcellular organelle-like arena where eSIRT2 promotes cancer cell metastasis via catalyzing extracellular protein deacetylation.

Indexed as

Lung NeoplasmsSirtuin 2AcetylationHumansProtein Processing, Post-TranslationalToll-Like Receptor 2Tumor MicroenvironmentSIRT2 protein, humanSirtuin 2Toll-Like Receptor 2acetylationlung cancermetastasissecretionSIRT2

Identifiers

PMID36453571
PMCPMC9875677
OpenAlexW4310567868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.